Clinical Trial Update: S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating S0816 FDG F-18 PET/CT imaging with or without additional chemotherapy and G-CSF in stage III/IV Hodgkin lymphoma; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• S0816 Fludeoxyglucose F 18-PET/CT Imaging

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma, Nonneoplastic Condition | Phase 2 | Status: COMPLETED | Results posted: 2018-04-04